International Clinical Trial: A Study in Adult Volunteers to Understand the Safety and Effects of a New Drug, PTC612 - Part 4 (Biomarker Evaluation in Participants With Elevated Baseline Inflammation)

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ACTRN12626001204336) titled 'A Study in Adult Volunteers to Understand the Safety and Effects of a New Drug, PTC612 - Part 4 (Biomarker Evaluation in Participants With Elevated Baseline Inflammation)' on Sept. 29.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Blinded (masking used)

Primary Sponsor: PTC Therapeutics, Inc.

Condition: inflammatory diseases inflammatory diseases Inflammatory and Immune System - Other inflammatory or immune system disorders

Intervention: Part 4 of the study involves a multiple-dose evaluation of PTC612 compared with placebo in eligible partic...